Relmada Therapeutics, Inc. (RLMD)
| Previous Close | 3.6800 |
| Open | 3.7600 |
| Bid | 3.8300 x 100 |
| Ask | 3.9000 x 300 |
| Day's Range | 3.6600 - 4.0000 |
| 52 Week Range | 2.3600 - 7.2230 |
| Volume | |
| Avg. Volume | 178,893 |
| Market Cap | 116.171M |
| Beta (5Y Monthly) | 0.19 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Relmada Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024
Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that it will report its financial results for the first quarter ended March 31, 2024 after the market close on Wednesday, May 8, 2024. The company will host a corporate update conference call and live audio webcast at 4:30 p.m. Eastern Time on Wednesday, May 8, 2024.
- PR Newswire
Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today provided a corporate update and announced preliminary and unaudited financial results for the fourth quarter and full year ended December 31, 2023. The Company will host a conference call today, Tuesday, March 19, at 4:30 PM Eastern Time/1:30 PM Pacific Time.
- PR Newswire
Relmada Therapeutics to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call and Webcast on March 19, 2024
Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that it will report its financial results for the fourth quarter and full-year ended December 31, 2023 after the market close on Tuesday, March 19, 2024. The company will host a corporate update conference call and live audio webcast at 4:30 p.m. Eastern Time on Tuesday, March 19, 2024.
